Oxytocin Side Effects and Benefits: Research Data
What the approved label lists as oxytocin side effects, what the bonding, trust, autism and obesity research found, why intranasal studies are hard to interpret, and where regulators stand.
Update History ▾
Research-use-only framing applied throughout in line with Remy editorial standards.
Oxytocin side effects are best documented for its one approved use, injections in childbirth: the label lists uterine overstimulation, water intoxication from its antidiuretic effect, nausea, vomiting, heart rhythm changes and, in the baby, a slow heart rate and jaundice.[1] Outside childbirth, short trials of nasal oxytocin reported adverse events similar to placebo, but none ran longer than 24 weeks.[2][3]
Its research benefits are narrower than the “love hormone” reputation suggests. The trust finding did not replicate, and the largest autism and obesity trials were negative on their main outcomes.[4][5][2][3] Remy Research supplies oxytocin for in-vitro laboratory research only.
What Is Oxytocin?
Oxytocin is a nine-amino-acid peptide hormone, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly, with a glycine amide at the end and a disulfide bond closing the first six residues into a ring. It is cut from a larger precursor that also yields its carrier protein, neurophysin 1.[6] The approved US injection is made synthetically to avoid contamination with vasopressin, a closely related hormone.[1]
How Oxytocin Works: Hypothalamus, Pituitary Gland and Oxytocin Receptors
Oxytocin is made mainly by large neurons in the hypothalamus and released into the blood from the posterior pituitary gland in response to suckling, labor and some forms of stress. The same neurons project to many brain areas, and the uterus, placenta, testis and heart also make oxytocin. Oxytocin receptors are G-protein-coupled receptors that signal mainly through Gq and phospholipase C.[7]
Gene-deletion studies narrowed which effects of oxytocin are essential. Mice unable to make oxytocin mated, gave birth and cared for their young, but their pups died unless oxytocin was given, because milk ejection failed.[8] Breastfeeding, not childbirth, was the function that could not proceed without it.
Oxytocin Side Effects: What the Approved Label Lists
Because the approved clinical uses are obstetric, the safety data describe patients in labor and their babies, not healthy volunteers, and many listed effects are complications of labor treatment. The prescribing information reports these adverse reactions:[1]
| Who | Reported adverse reactions | Source |
|---|---|---|
| Mother | Anaphylactic reaction, postpartum hemorrhage, cardiac arrhythmia, premature ventricular contractions, nausea, vomiting | Approved label |
| Mother, serious | Rupture of the uterus, hypertensive episodes, subarachnoid hemorrhage, pelvic hematoma, fatal afibrinogenemia | Approved label |
| Fetus or newborn | Bradycardia, arrhythmias, low Apgar scores, neonatal jaundice, retinal hemorrhage, seizures | Approved label |
| Water balance | Water intoxication, with convulsions and coma in severe cases | Approved label |
- Uterine overstimulation. Excessive dosage or hypersensitivity can cause uterine hypertonicity, spasm, tetanic contraction or rupture of the uterus.[1]
- Water intoxication. Oxytocin has an intrinsic antidiuretic effect, increasing water reabsorption by the kidney. Severe water intoxication with convulsions and coma has occurred during a prolonged infusion, and maternal death from oxytocin-induced water intoxication has been reported.[1]
- Blood pressure and heart. The maternal list includes hypertensive episodes, cardiac arrhythmia and premature ventricular contractions.[1]
- Contraindications. Antepartum use is contraindicated in situations such as significant cephalopelvic disproportion, fetal distress where delivery is not imminent, a hyperactive or hypertonic uterus, or where vaginal delivery is contraindicated, and in hypersensitivity to the drug.[1]
- Half-life. The plasma half-life is about 1 to 6 minutes, shorter in late pregnancy and during lactation.[1]
These are labelled risks of an approved obstetric medicine. They are not a measure of the effects of oxytocin in other settings, where long-term data do not exist.
Oxytocin Benefits: Approved Use and Research Findings
| Claimed benefit | What was reported | Evidence type |
|---|---|---|
| Labor and bleeding | Injections start or strengthen contractions and control bleeding after delivery | Approved use, trials |
| Milk ejection | Required for nursing in mice | Animal (knockout) |
| Pair bonding | Linked to partner preference in voles; receptor-null voles still bond | Animal |
| Trust | A 2005 result did not replicate in larger preregistered studies | Human experiments |
| Autism | No difference from placebo in 290 children and adolescents | Human RCT |
| Weight loss | No change in body weight over 8 weeks in 61 adults | Human RCT |
| Sexual behavior | Facilitates it in animals; human nasal studies did not confirm | Animal, human |
Childbirth: Inducing Labor and Preventing Bleeding
In the US, oxytocin injection is approved before delivery to start or improve uterine contractions when there is a medical reason, and after delivery to produce contractions in the third stage of labor and control bleeding. It is not indicated for elective induction of labor.[1] It has been on the WHO Model List of Essential Medicines since 1977.[9] Its benefit is a reduced risk of heavy bleeding: a 2019 Cochrane review found that preventive oxytocin given to women after birth roughly halved the risk of losing 500 mL of blood or more compared with no uterotonic or placebo (risk ratio 0.51; 6 studies, 4,162 women; low-quality evidence).[10]
The “Love Hormone” and Bonding Hormone Research
The bonding hormone label, and the idea of oxytocin as a driver of social bonding, comes from animal work. In monogamous female prairie voles, oxytocin produced a partner preference without mating, and an oxytocin blocker prevented the preference that normally follows mating.[11] But voles engineered to lack oxytocin receptors still formed pair bonds, gave birth and raised young to weaning.[12]
In people, a 2005 Nature study reported that intranasal oxytocin increased trust in an economic game.[13] A preregistered replication with more than 95% power found no effect, and a 2026 registered report of 211 people, pooled with it to 532, found no evidence that oxytocin increases trusting behavior.[4][5]
Autism, Social Cognition and Weight
SOARS-B, a 24-week placebo-controlled trial in 290 children and adolescents with autism, found no difference in social withdrawal scores (−3.7 against −3.5; P=0.61), with adverse events similar in both groups.[2] In an 8-week trial of 61 adults with obesity, intranasal oxytocin did not change body weight (a change of 0.20 kg against 0.26 kg on placebo), body fat or energy expenditure, although intake at one test meal was lower; there were no serious adverse events.[3]
Intranasal Oxytocin Research and Oxytocin Levels
Almost all research outside obstetrics uses intranasal oxytocin administration, and researchers still treat it as investigational. The only nasal oxytocin product in Drugs@FDA, Syntocinon nasal solution, is listed as discontinued.[14] Two 2016 reviews in Biological Psychiatry urged caution: one concluded that intranasal oxytocin studies are generally underpowered and that most published positive findings are probably not true effects;[15] the other noted that very little intranasal oxytocin appears to reach the cerebrospinal fluid while plasma oxytocin rises far above normal, and that many measurements of oxytocin levels used discredited methods.[16] A 2020 study in rhesus macaques did detect labelled oxytocin in several brain areas after intranasal oxytocin administration, but not after intravenous administration, so the mechanisms and extent of brain entry in people are still debated.[17]
Oxytocin for Men: Sexual Arousal and Behavior Studies
Oxytocin plays a role in social and sexual behaviors, and its involvement in erectile function was one of the first central effects found in laboratory animals in the 1980s; in animals, oxytocin facilitates sexual behavior in males and females, through mechanisms that involve other neurotransmitters and neuropeptides. A 2021 review of studies using intranasal oxytocin in men and women found that the human results did not confirm that facilitatory role.[18] A 2026 review of 76 studies in sexual medicine likewise described oxytocin as biologically plausible but with limited data on effectiveness.[19]
Is Oxytocin FDA Approved?
- United States. Oxytocin injection (Pitocin and generic versions) is FDA-approved for the obstetric uses above only; it is not indicated for elective induction.[1]
- Nasal products. Syntocinon nasal solution is listed in Drugs@FDA as discontinued; nasal use in research is investigational.[14]
- WHO. Oxytocin is an essential medicine for postpartum haemorrhage.[9]
- Sport. Oxytocin is not named on WADA’s 2027 Prohibited List; class S0 covers only substances with no current approval for human therapeutic use.[20]
- UAE. Remy Research sells oxytocin for in-vitro laboratory research only, not for human or veterinary use.
Oxytocin vs Related Peptides
Oxytocin is often discussed alongside other neuropeptides studied for social and sexual behavior. PT-141 (bremelanotide) acts on melanocortin receptors and is approved for low sexual desire in premenopausal women; kisspeptin acts at the top of the reproductive hormone axis and remains investigational.[19] See the PT-141 melanocortin research review, HCG vs gonadorelin vs kisspeptin and the VIP research review. For chemistry, history and the full source list, read the oxytocin peptide research review.
What Oxytocin Research Does Not Yet Show
- A replicated social effect in people. The best-known trust result failed in larger preregistered studies.[4][5]
- A positive large trial outside childbirth. The largest autism and obesity trials were negative on their main outcomes.[2][3]
- Long-term safety outside obstetrics. Non-obstetric trials lasted 24 weeks or less.[2][3]
- Settled brain delivery. How much intranasal oxytocin reaches the human brain is still debated.[16][17]
These gaps are not arguments against studying oxytocin. They are arguments against overselling it.
Oxytocin for Laboratory Research
Remy Research supplies oxytocin for in-vitro research as the Genovare Oxytocin 40mg AQ pen. Each product page carries its batch testing details.
Our Research Standards
This article prioritizes the approved prescribing information, randomized trials, preregistered replications and regulator records, and keeps approved, animal and experimental human evidence apart. No therapeutic, dosing or administration guidance is given. Read our editorial policy →
Oxytocin Side Effects FAQ
What are the side effects of oxytocin?
For the approved obstetric injection, the label lists nausea, vomiting, cardiac arrhythmia, hypertensive episodes, postpartum hemorrhage, anaphylaxis, uterine rupture and water intoxication in the mother, and slow heart rate, jaundice and retinal hemorrhage in the newborn.[1]
Why can oxytocin cause water intoxication?
Oxytocin has an intrinsic antidiuretic effect, increasing water reabsorption by the kidney. Severe water intoxication with convulsions and coma has been reported during prolonged infusion.[1]
Is oxytocin FDA approved?
Yes, as an injection for obstetric use: to start or strengthen labor contractions when there is a medical reason, and to control bleeding after delivery. It is not indicated for elective induction.[1]
Is oxytocin safe?
Does oxytocin nasal spray work?
Is oxytocin the love hormone?
Is there oxytocin in males?
Is oxytocin a peptide hormone?
Yes. It is a nine-amino-acid peptide with a disulfide ring and an amidated C-terminus, made from a precursor that also yields neurophysin 1.[6]
Is oxytocin banned in sport?
It is not named on WADA’s 2027 Prohibited List, and as an approved medicine it falls outside the S0 clause for unapproved substances.[20]
Sources
- Pitocin (oxytocin injection, USP) prescribing information, DailyMed, updated May 6, 2026. dailymed.nlm.nih.gov ↩
- Sikich L, Kolevzon A, King BH, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 2021;385(16):1462-1473. doi: 10.1056/NEJMoa2103583 · PMID: 34644471 ↩
- Plessow F, Kerem L, Wronski ML, et al. Intranasal Oxytocin for Obesity. NEJM Evid. 2024;3(5):EVIDoa2300349. doi: 10.1056/EVIDoa2300349 · PMID: 38815173 ↩
- Declerck CH, Boone C, Pauwels L, et al. A registered replication study on oxytocin and trust. Nat Hum Behav. 2020;4(6):646-655. doi: 10.1038/s41562-020-0878-x · PMID: 32514040 ↩
- Kroll CF, Schruers KRJ, Viechtbauer W, et al. Absence of a meaningful effect of intranasal oxytocin on trusting behavior: a registered report with pooled equivalence testing. Cortex. 2026;198:208-233. doi: 10.1016/j.cortex.2026.03.006 · PMID: 41880977 ↩
- UniProt Consortium. UniProtKB P01178, oxytocin-neurophysin 1 proprotein (human): oxytocin CYIQNCPLG with a Cys1–Cys6 disulfide and a C-terminal glycine amide. uniprot.org/uniprotkb/P01178 ↩
- Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629-683. doi: 10.1152/physrev.2001.81.2.629 · PMID: 11274341 ↩
- Nishimori K, Young LJ, Guo Q, et al. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A. 1996;93(21):11699-11704. doi: 10.1073/pnas.93.21.11699 · PMID: 8876199 ↩
- World Health Organization. Electronic Essential Medicines List: oxytocin, first added in 1977, uterotonics, for postpartum haemorrhage. list.essentialmeds.org ↩
- Salati JA, Leathersich SJ, Williams MJ, et al. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2019;4(4):CD001808. doi: 10.1002/14651858.CD001808.pub3 · PMID: 31032882 ↩
- Insel TR, Hulihan TJ. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav Neurosci. 1995;109(4):782-789. doi: 10.1037//0735-7044.109.4.782 · PMID: 7576222 ↩
- Berendzen KM, Sharma R, Mandujano MA, et al. Oxytocin receptor is not required for social attachment in prairie voles. Neuron. 2023;111(6):787-796.e4. doi: 10.1016/j.neuron.2022.12.011 · PMID: 36708707 ↩
- Kosfeld M, Heinrichs M, Zak PJ, et al. Oxytocin increases trust in humans. Nature. 2005;435(7042):673-676. doi: 10.1038/nature03701 · PMID: 15931222 ↩
- U.S. Food and Drug Administration. Drugs@FDA, NDA 012285: Syntocinon (oxytocin) nasal solution, marketing status “Discontinued” (checked via openFDA October 27, 2026). accessdata.fda.gov ↩
- Walum H, Waldman ID, Young LJ. Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies. Biol Psychiatry. 2016;79(3):251-257. doi: 10.1016/j.biopsych.2015.06.016 · PMID: 26210057 ↩
- Leng G, Ludwig M. Intranasal Oxytocin: Myths and Delusions. Biol Psychiatry. 2016;79(3):243-250. doi: 10.1016/j.biopsych.2015.05.003 · PMID: 26049207 ↩
- Lee MR, Shnitko TA, Blue SW, et al. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nat Commun. 2020;11(1):2783. doi: 10.1038/s41467-020-15942-1 · PMID: 32494001 ↩
- Melis MR, Argiolas A. Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances. Int J Mol Sci. 2021;22(19):10376. doi: 10.3390/ijms221910376 · PMID: 34638719 ↩
- Vasylieva V, West A, Karpman E. Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review. Sex Med Rev. 2026;14(4):qeag078. doi: 10.1093/sxmrev/qeag078 · PMID: 42862021 ↩
- World Anti-Doping Agency. 2027 Prohibited List, in force from January 1, 2027 (oxytocin is not named; class S0 covers substances with no current governmental approval for human therapeutic use). wada-ama.org ↩
For catalog details, see the Genovare Oxytocin 40mg AQ pen. For editorial standards, continue to the editorial policy.